STELLA PHARMA CORPORATION Logo

STELLA PHARMA CORPORATION

Develops boron compounds for Boron Neutron Capture Therapy (BNCT) to treat cancer.

4888 | T

Overview

Corporate Details

ISIN(s):
JP3399680002
LEI:
Country:
Japan
Address:
大阪市中央区高麗橋三丁目2番7号 ORIX高麗橋ビル

Description

Stella Pharma Corporation is a pharmaceutical company focused on the research and development of therapeutic drugs. The company specializes in boron compounds for Boron Neutron Capture Therapy (BNCT), a form of targeted radiation therapy for cancer. As a pioneer in the field, Stella Pharma developed the boron-based drug used in the first approved BNCT treatment for unresectable head and neck cancers. Its development pipeline is focused on expanding the application of BNCT to other difficult-to-treat malignancies, with clinical trials investigating its use for conditions such as cutaneous angiosarcoma.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2022-02-14 05:30
四半期報告書-第15期第3四半期(令和3年10月1日-令和3年12月31日)
Japanese ZIP 144.3 KB
2021-11-11 05:30
四半期報告書-第15期第2四半期(令和3年7月1日-令和3年9月30日)
Japanese ZIP 163.1 KB
2021-08-06 08:30
四半期報告書-第15期第1四半期(令和3年4月1日-令和3年6月30日)
Japanese ZIP 138.3 KB
2021-06-30 06:01
確認書
Japanese ZIP 8.1 KB
2021-06-30 06:00
有価証券報告書-第14期(令和2年4月1日-令和3年3月31日)
Japanese ZIP 967.3 KB
2021-04-13 08:00
訂正有価証券届出書(新規公開時)
Japanese ZIP 2.1 MB
2021-04-05 03:00
訂正有価証券届出書(新規公開時)
Japanese ZIP 2.1 MB
2021-03-19 07:00
有価証券届出書(新規公開時)
Japanese ZIP 4.2 MB

Automate Your Workflow. Get a real-time feed of all STELLA PHARMA CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for STELLA PHARMA CORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for STELLA PHARMA CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.